Healthcare -
Biotechnology - NASDAQ - US
$ 46.52
-0.853 %
$ 1.78 B
Market Cap
-12.41
P/E
TARS - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity TARS - Tarsus Pharmaceuticals, Inc.
265 M
LAST VALUE
21.82%
2 YEAR CAGR
156.55%
5 YEAR CAGR
0.00%
10 YEAR CAGR